市場調查報告書
商品編碼
1433402
全球實驗室能力驗證市場2023-2030Global Laboratory Proficiency Testing Market 2023-2030 |
全球實驗室能力驗證市場在預測期間(2023-2030年)預計CAGR為7.4%。市場的成長歸因於全球產業對品質保證的需求。品質保證是各行業(尤其是食品和飲料行業)的首要任務,以維持消費者的信任並遵守監管標準。能力驗證確保了實驗室測試程序的可靠性。2022年 4月,BIPEA 啟動了一項新的實驗室間測試(PTS 111),讓實驗室檢測食品中的 SEA 至 SEE 型葡萄球菌腸毒素。它指定了用於初步測試的牛奶基質,評估液態牛奶樣本中葡萄球菌腸毒素的檢測。
全球實驗室能力驗證市場依行業類型和技術進行細分。根據行業類型,市場分為臨床診斷、微生物學、製藥、生物製劑等。此外,根據技術,市場細分為聚合酶鏈反應、免疫分析、色譜法、光譜法等。臨床診斷子類別預計將佔據該行業類型細分市場的很大一部分市場佔有率。這種成長可歸因於複雜診斷測試的發展、早期診斷的需求以及對精確可靠測試過程的需求增加。
在行業類型中,微生物學細分市場預計將在全球實驗室能力驗證市場中佔據相當大的佔有率。該細分市場的成長歸因於微生物學技術的不斷進步。微生物測試方法和技術能夠更準確、更全面地識別化妝品配方的微生物污染,推動了能力驗證產業的發展。例如,2023年8月,BIPEA推出了最新的能力測試PT 114化妝品微生物挑戰測試。該計劃的目的是獨立評估實驗室在化妝品配方中進行微生物挑戰測試的能力。
全球實驗室能力驗證市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於醫療保健意識不斷提高以及越來越多的實驗室尋求在該地區獲得國際認證,預計亞太地區將在全球市場中佔據顯著佔有率。
在所有地區中,北美地區預計在預測期內將以相當大的CAGR成長。區域成長歸因於對提高測試準確性和置信度的需求不斷成長。能力驗證計劃依賴測試準確性,這對於準確診斷 COVID-19 非常重要。為了提高整體準確性,該程序允許實驗室分析整個操作過程,包括樣品處理和測試程序。例如,2020年 4月,美國病理學家學會(CAP)發布了一項新的能力驗證(PT)計劃,用於檢測嚴重急性呼吸症候群冠狀病毒 2(SARS CoV-2)。微生物學委員會試點了一個用於 SARS CoV-2 檢測的創新項目,提供非傳染性樣本並允許實驗室檢查整個操作過程。
服務於實驗室能力驗證市場的主要公司包括 AOAC INTERNATIONAL、Laboratory Corp.、LGC Ltd.、Merck KGaA、Thermo Fisher Scientific Inc 等。市場參與者透過各種策略(包括併購、夥伴關係、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2022年 4月,Spex CertiPrep、NSI Lab Solutions 和美國藥典(USP)合作,為全球實驗室提供強大的能力驗證(PT)計畫。該計劃提高實驗室和分析師的績效意識,支持認證要求,增強品質管理體系,提高行業可靠性,並確保整個產品註冊和耐久性的監管機構保證。
Global Laboratory Proficiency Testing Market Size, Share & Trends Analysis Report by Industry Type (Clinical Diagnostics, Microbiology, Pharmaceuticals, Biologics, and Others), and by Technology (Polymerase Chain Reaction, Immunoassays, Chromatography, Spectrometry, and Others), Forecast Period (2023-2030)
The global laboratory proficiency testing market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). The market's growth is attributed to the demand for quality assurance in the industry across the globe. The quality assurance is prioritized in industries, particularly in food and beverage, to maintain consumer trust and compliance with regulatory standards. The proficiency testing ensures the dependability of laboratory testing procedures. in April 2022,BIPEA is launched a new interlaboratory test (PTS 111) that allowed laboratories to detect Staphylococcal enterotoxins type SEA to SEE in food. It specifies milk matrix for preliminary testing, assessing staphylococcal enterotoxins detection in liquid milk samples.
The global laboratory proficiency testing market is segmented on the industry type, and technology. Based on the industry type, the market is sub-segmented into clinical diagnostics, microbiology, pharmaceuticals, biologics, and others. Furthermore, on the basis of technology, the market is sub-segmented into polymerase chain reaction, immunoassays, chromatography, spectrometry, and others. The clinical diagnostics subcategory is expected to capture a significant portion of the market share within the industry type segment. The growth can be attributed to the development of sophisticated diagnostic tests the need for early diagnosis, and the increased need for precise and reliable testing processes.
Among the industry type, the microbiology sub-segment is expected to hold a considerable share of the global Laboratory Proficiency Testing market. The segmental growth is attributed to the growing technological advancements in microbiology. The microbiological testing methodologies and technology that enable more accurate and comprehensive identification of microbial contamination of cosmetic formulations boost the proficiency testing industry. For instance, in August 2023, BIPEA launched latest proficiency test, PT 114 the Cosmetic Microbial Challenge test. The purpose of the program is to independently assess a laboratory's the ability to perform a Microbial Challenge test in cosmetic formulations.
The global laboratory proficiency testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising awareness of healthcare and a growing number of laboratories seeking to obtain international credentials in the region.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising demand for enhancing test accuracy and confidence. The proficiency testing programs develop dependence on testing accuracy, that's essential to accurate COVID-19 diagnosis. To improve overall accuracy, the program allows laboratories to analyze the whole operating process, including sample handling and testing procedures. For instance, in April 2020, The College of American Pathologists (CAP), released a new proficiency testing (PT) program for the detection of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). The Microbiology Committee piloted an innovative project for SARS CoV-2 detection, delivering non-infectious samples and allowing laboratories to examine the complete operation.
The major companies serving the laboratory proficiency testing market includes AOAC INTERNATIONAL, Laboratory Corp., LGC Ltd., Merck KGaA, Thermo Fisher Scientific Inc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Spex CertiPrep, NSI Lab Solutions, and the US Pharmacopeia (USP) partnered to provide a robust proficiency testing (PT) program for laboratories across the globe. The program raises laboratory and analyst performance awareness, supports the requirements for accreditation, enhances quality management systems, promotes industry reliability, and ensures regulator assurance across the product registration and durability.